Gfunk6

And to think . . . I hesitated
Moderator Emeritus
Lifetime Donor
15+ Year Member
Apr 16, 2004
3,635
710
SF Bay Area
Status
Attending Physician
Hot off the presses from JAMA Oncology (http://oncology.jamanetwork.com/article.aspx?articleid=2546172):

Of 125 guideline authors, 108 (86%) had at least 1 reported FCOI. Authors received an average of $10 011 (range, $0-$106 859) in general payments (GPs), which include consulting, meals, lodging, and similar transfers of value, and $236 066 (range $0-$2 756 713) in industry research payments (RPs), including funding associated with clinical trials. Approximately 84% of authors received GPs, while 47% received RPs. Eight (6%) had FCOIs in excess of the $50 000 net and/or $20 000 single-company maximums stipulated by NCCN.
Where there is smoke, there is fire . . .
 
Feb 9, 2016
53
20
Status
Occupational Therapist
haha cant be surprised about this; how else does surgery for high risk prostate or for surgery for multiply node positive head and neck oropharynx possibly end up as treatment recommendations.
 

medgator

Senior Member
15+ Year Member
Sep 20, 2004
4,850
1,663
Status
Attending Physician
Most of the $$$ was RP, research payments.

Can't say I'm shocked, and while not ideal, it's going to happen if you have academicians writing the guidelines